Literature DB >> 12466969

Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth.

Ming-Tat Ling1, Xianghong Wang, Xue-Song Ouyang, Terence K W Lee, Tian-Yong Fan, Kexin Xu, Sai-Wah Tsao, Y C Wong.   

Abstract

The helix-loop-helix protein Id-1 has been suggested to play a positive role in cell proliferation and tumorigenesis of many types of human cancers. However, little is known about the molecular mechanism involved in the function of Id-1. In this study, using four stable Id-1 transfectant clones, we investigated the involvement of MAPK signaling pathway in the Id-1 induced serum independent prostate cancer cell growth. Our results demonstrated that both transient and stable ectopic Id-1 expression in prostate cancer LNCaP cells led to activation of the Raf/MEK1/2 signaling pathway. In addition, inhibition of MEK1/2 phosphorylation by one of its inhibitors, PD098059, resulted in the decreased cell cycle S phase fraction and cell growth rate, suggesting that activation of MAPK signaling pathway is essential for Id-1 induced prostate cancer cell proliferation. Furthermore, treatment with antisense oligonucleotide complementary to Id-1 mRNA in PC-3 and DU145 cells resulted in a decreased Id-1 expression which was accompanied by decreased Egr-1 protein. Our results suggest for the first time that the function of Id-1 is associated with MAPK signaling pathway activation and indicate a possible novel mechanism in which Id-1 regulates prostate cancer cell growth and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466969     DOI: 10.1038/sj.onc.1206007

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.

Authors:  Ling Zhang; Xi Shen; Qing Lu; Qingwei Zhou; Jiaqi Gu; Renbao Gan; Hui Zhang; Xiaodong Sun; Bing Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

Review 2.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

3.  Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers.

Authors:  Min Khine Maw; Jiro Fujimoto; Teruhiko Tamaya
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

4.  The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.

Authors:  Yan-Ping Zhang; Kai-Long Liu; Zhan Yang; Bao-Sai Lu; Jin-Chun Qi; Zhen-Wei Han; Yue-Wei Yin; Ming Zhang; De-Min Chen; Xiao-Wei Wang; Wei Li; Hong Xin
Journal:  Cell Cycle       Date:  2019-08-25       Impact factor: 4.534

5.  ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

Authors:  Hao Geng; Brooks L Rademacher; Janet Pittsenbarger; Chung-Ying Huang; Christopher T Harvey; Marie C Lafortune; Anne Myrthue; Mark Garzotto; Peter S Nelson; Tomasz M Beer; David Z Qian
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

6.  Signal transduction by M3 muscarinic acetylcholine receptor in prostate cancer.

Authors:  Liqiang Guo; Yuqiang Liu; Zhibo Ding; Wendong Sun; Mingzhen Yuan
Journal:  Oncol Lett       Date:  2015-10-27       Impact factor: 2.967

7.  Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.

Authors:  Divya Patel; Ashley E Knowell; Maxwell Korang-Yeboah; Pankaj Sharma; Jugal Joshi; Shanora Glymph; Swathi Chinaranagari; Peri Nagappan; Ravi Palaniappan; Nathan J Bowen; Jaideep Chaudhary
Journal:  Mol Endocrinol       Date:  2014-06-12

8.  Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.

Authors:  Meisong Lu; Lan Xiao; Jianli Hu; Suo Deng; Yan Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

9.  Prostate cancer-associated gene expression alterations determined from needle biopsies.

Authors:  David Z Qian; Chung-Ying Huang; Catherine A O'Brien; Ilsa M Coleman; Mark Garzotto; Lawrence D True; Celestia S Higano; Robert Vessella; Paul H Lange; Peter S Nelson; Tomasz M Beer
Journal:  Clin Cancer Res       Date:  2009-04-14       Impact factor: 12.531

10.  Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1.

Authors:  H-F Yuen; Y-T Chiu; K-K Chan; Y-P Chan; C-W Chua; C M McCrudden; K-H Tang; M El-Tanani; Y-C Wong; X Wang; K-W Chan
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.